186 related articles for article (PubMed ID: 1701833)
21. The synthesis of 11 beta-methoxy-[16 alpha-123I] iodoestradiol and its interaction with the estrogen receptor in vivo and in vitro.
Zielinski JE; Larner JM; Hoffer PB; Hochberg RB
J Nucl Med; 1989 Feb; 30(2):209-15. PubMed ID: 2738649
[TBL] [Abstract][Full Text] [Related]
22. Interactions of 16alpha-[18F]-fluoroestradiol (FES) with sex steroid binding protein (SBP).
Tewson TJ; Mankoff DA; Peterson LM; Woo I; Petra P
Nucl Med Biol; 1999 Nov; 26(8):905-13. PubMed ID: 10708304
[TBL] [Abstract][Full Text] [Related]
23.
Xu D; Zhuang R; You L; Guo Z; Wang X; Peng C; Zhang D; Zhang P; Wu H; Pan W; Zhang X
Nucl Med Biol; 2018 Apr; 59():48-55. PubMed ID: 29466767
[TBL] [Abstract][Full Text] [Related]
24. Carbon-11-labeled estrogens as potential imaging agents for breast tumors.
Dence CS; Napolitano E; Katzenellenbogen JA; Welch MJ
Nucl Med Biol; 1996 May; 23(4):491-6. PubMed ID: 8832705
[TBL] [Abstract][Full Text] [Related]
25. Characterization of 11 beta-methoxy-16 alpha-[125I]iodoestradiol binding: neuronal localization of estrogen-binding sites in the developing rat brain.
Brown TJ; MacLusky NJ; Toran-Allerand CD; Zielinski JE; Hochberg RB
Endocrinology; 1989 May; 124(5):2074-88. PubMed ID: 2468470
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, estrogen receptor binding, and tissue distribution of [18F]fluorodoisynolic acids.
Scribner AW; Jonson SD; Welch MJ; Katzenellenbogen JA
Nucl Med Biol; 1997 Apr; 24(3):209-24. PubMed ID: 9228655
[TBL] [Abstract][Full Text] [Related]
27. Analysis of blood clearance and labeled metabolites for the estrogen receptor tracer [F-18]-16 alpha-fluoroestradiol (FES).
Mankoff DA; Tewson TJ; Eary JF
Nucl Med Biol; 1997 May; 24(4):341-8. PubMed ID: 9257333
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, receptor binding and biodistribution of the gem-21-chloro-21-iodovinylestradiol derivatives.
Ali H; Rousseau J; van Lier JE
J Steroid Biochem Mol Biol; 1993 Nov; 46(5):613-22. PubMed ID: 8240984
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological properties of 7alpha-cyano derivatives of the (17alpha,20E/Z)-[125I]iodovinyl- and 16alpha-[125I]iodo-estradiols.
Ali H; Rousseau J; Paquette B; Dubé C; Marko B; van Lier JE
Steroids; 2003 Dec; 68(14):1189-200. PubMed ID: 14643881
[TBL] [Abstract][Full Text] [Related]
30. In vivo imaging of brain estrogen receptors in rats: a 16α-18F-fluoro-17β-estradiol PET study.
Khayum MA; de Vries EF; Glaudemans AW; Dierckx RA; Doorduin J
J Nucl Med; 2014 Mar; 55(3):481-7. PubMed ID: 24481026
[TBL] [Abstract][Full Text] [Related]
31. 16 alpha-[77Br]bromo-11 beta-methoxyestradiol-17 beta: a gamma-emitting estrogen imaging agent with high uptake and retention by target organs.
Katzenellenbogen JA; McElvany KD; Senderoff SG; Carlson KE; Landvatter SW; Welch MJ
J Nucl Med; 1982 May; 23(5):411-9. PubMed ID: 7077395
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, estrogen receptor binding, and tissue distribution of a new iodovinylestradiol derivative (17alpha,20E)-21-[123I]Iodo-11beta-nitrato-19-norp regna-1,3,5 (10),20-tetraene-3,17-diol (E-[123I]NIVE).
Rijks LJ; van den Bos JC; van Doremalen PA; Boer GJ; de Bruin K; Doornbos T; Vekemans JA; Posthumus MA; Janssen AG; van Royen EA
Nucl Med Biol; 1998 May; 25(4):411-21. PubMed ID: 9639304
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and structure-affinity of a series of 7 alpha-undecylestradiol derivatives: a potential vector for therapy and imaging of estrogen-receptor-positive cancers.
DaSilva JN; van Lier JE
J Med Chem; 1990 Jan; 33(1):430-4. PubMed ID: 2296033
[TBL] [Abstract][Full Text] [Related]
34. Steroidal affinity labels of the estrogen receptor. 3. Estradiol 11 beta-n-alkyl derivatives bearing a terminal electrophilic group: antiestrogenic and cytotoxic properties.
Lobaccaro C; Pons JF; Duchesne MJ; Auzou G; Pons M; Nique F; Teutsch G; Borgna JL
J Med Chem; 1997 Jul; 40(14):2217-27. PubMed ID: 9216841
[TBL] [Abstract][Full Text] [Related]
35. Factors influencing the uptake of 18F-fluoroestradiol in patients with estrogen receptor positive breast cancer.
Peterson LM; Kurland BF; Link JM; Schubert EK; Stekhova S; Linden HM; Mankoff DA
Nucl Med Biol; 2011 Oct; 38(7):969-78. PubMed ID: 21982568
[TBL] [Abstract][Full Text] [Related]
36. Automated synthesis of 11beta-methoxy-4,16alpha-[16alpha-(18)F]difluoroestradiol (4F-M[(18)F]FES) for estrogen receptor imaging by positron emission tomography.
Ahmed N; Langlois R; Rodrigue S; Bénard F; van Lier JE
Nucl Med Biol; 2007 May; 34(4):459-64. PubMed ID: 17499736
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and evaluation of B-, C-, and D-ring-substituted estradiol carboxylic acid esters as locally active estrogens.
Labaree DC; Zhang JX; Harris HA; O'Connor C; Reynolds TY; Hochberg RB
J Med Chem; 2003 May; 46(10):1886-904. PubMed ID: 12723952
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, receptor binding, and tissue distribution of 7 alpha- and 11 beta-substituted (17 alpha,20E)- and (17 alpha,20Z)-21-[125I]iodo-19-norpregna-1,3,5(10),20-tetraene-3,17-diols.
Ali H; Rousseau J; Ghaffari MA; van Lier JE
J Med Chem; 1991 Feb; 34(2):854-60. PubMed ID: 1995909
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, receptor binding, and target-tissue uptake of carbon-11 labeled carbamate derivatives of estradiol and hexestrol.
Ouellet R; Rousseau J; Brasseur N; van Lier JE; Diksic M; Westera G
J Med Chem; 1984 Apr; 27(4):509-13. PubMed ID: 6323712
[TBL] [Abstract][Full Text] [Related]
40. Impact on estrogen receptor binding and target tissue uptake of [18F]fluorine substitution at the 16alpha-position of fulvestrant (faslodex; ICI 182,780).
Seimbille Y; Bénard F; Rousseau J; Pepin E; Aliaga A; Tessier G; van Lier JE
Nucl Med Biol; 2004 Aug; 31(6):691-8. PubMed ID: 15246359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
